August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS32
Academic Journal
Presents an abstract of the research manuscript `In vitro preclinical studies of gene transfer in multiple myeloma,' by S. Trudel, R.G. Hawley et al from the Toronto Hospital.


Related Articles

  • Double-hit myeloma with IGH/ MYC and IGH/ CCND1 translocations. Ji, Misuk; Jang, Seongsoo; Lee, Je-Hwan; Seo, Eul-Ju // Annals of Hematology;Aug2013, Vol. 92 Issue 8, p1129 

    A letter to the editor is presented related to the case report of a woman with lower back pain and has suffered from plasma cell myeloma (PCM), involving the translocation of genes Immunoglobin heavy (IGH)/myelocytomatosis viral oncogene (MYC) and Immunoglobin (IGH)/Cyclin D1 (CCNDI).

  • Multiple myeloma and related conditions. Singer, Charles R J // BMJ: British Medical Journal (International Edition);03/29/97, Vol. 314 Issue 7085, p960 

    Features the treatment of multiple myeloma. Clinical features; Investigations and diagnosis; Conditions associated with M proteins; Minimal diagnostic criteria; Management and clinical course.

  • LETTER FROM THE EDITOR-IN-CHIEF. Lonial, Sagar // Personalized Medicine in Oncology;Feb2014, Vol. 3 Issue 1, p24 

    No abstract available.

  • The Myeloma Survival Guide. Faiman, Beth // Oncology Nurse-APN/PA;Sep/Oct2014, Vol. 7 Issue 5, p19 

    No abstract available.

  • Expert comment. Lobban, Lois // Nursing Standard;5/28/2014, Vol. 28 Issue 39, p18 

    In this article the author offers her opinions on the treatment of patients with multiple myeloma.

  • Multiple myeloma incidence. Harras, Angela // JNCI: Journal of the National Cancer Institute;1/05/94, Vol. 86 Issue 1, p9 

    Presents a graph showing the incidence of multiple myeloma in Americans in 1993. Prognosis; Genetic and environmental links.

  • International uniform response criteria for multiple myeloma. Durie, B G M; Harousseau, J-L; Miguel, J S; Bladé, J; Barlogie, B; Anderson, K; Gertz, M; Dimopoulos, M; Westin, J; Sonneveld, P; Ludwig, H; Gahrton, G; Beksac, M; Crowley, J; Belch, A; Boccadaro, M; Turesson, I; Joshua, D; Vesole, D; Kyle, R // Leukemia (08876924);Dec2006, Vol. 20 Issue 12, p2220 

    A correction to the article "International Uniform Response Criteria for Multiple Myeloma" that was published in a previous issue is presented.

  • Erratum to: pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients. Buda, Gabriele; Orciuolo, Enrico; Galimberti, Sara; Pelosini, Matteo; Petrini, Mario // Annals of Hematology;Jul2011, Vol. 90 Issue 7, p863 

    A correction to the article "Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients," that was published in the previous issue is presented.

  • International uniform response criteria for multiple myeloma. Durie1, B G M; Harousseau2, J-L; Miguel3, J S; Bladé4, J; Barlogie5, B; Anderson6, K; Gertz7, M; Dimopoulos8, M; Westin9, J; Sonneveld10, P; Ludwig11, H; Gahrton12, G; Beksac13, M; Crowley14, J; Belch15, A; Boccadaro16, M; Turesson17, I; Joshua18, D; Vesole19, D; Kyle7, R // Leukemia (08876924);May2007, Vol. 21 Issue 5, p1134 

    A correction to the article about multiple myeloma that was published in the 2006 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics